Clinical trial
A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
NCT02685137 is registered in ClinicalTrials.gov with InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
- Lead sponsor
- InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 1, 2002
- Completion date
- February 28, 2013
- Enrollment
- 185 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.